Q4 2023 update: M&A activity in pharmaceutical in Europe
In the Europe pharmaceutical industry, there were 87 M&A deals announced in Q4 2023, worth a total value of $9.2bn, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: M&A activity in pharmaceutical in Asia-Pacific
In the Asia-Pacific pharmaceutical industry, there were 104 M&A deals announced in Q4 2023, worth a total value of $16.1bn, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: M&A activity in pharmaceutical in North America
In the North America pharmaceutical industry, there were 228 M&A deals announced in Q4 2023, worth a total value of $64.8bn, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: private equity deals in pharmaceutical in Europe
In the Europe pharmaceutical industry, there were 21 private equity deals announced in Q4 2023, worth a total value of $559.2m, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: private equity deals in pharmaceutical in Asia-Pacific
In the Asia-Pacific pharmaceutical industry, there were 10 private equity deals announced in Q4 2023, worth a total value of $2.5bn, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: M&A activity in pharmaceutical in Australia
In Australia pharmaceutical industry, there were 6 M&A deals announced in Q4 2023, worth a total value of $276.3m, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: M&A activity in pharmaceutical in Singapore
In Singapore pharmaceutical industry, there were 7 M&A deals announced in Q4 2023, worth a total value of $1.4bn, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: private equity deals in pharmaceutical in India
In India pharmaceutical industry, there were 3 private equity deals announced in Q4 2023, worth a total value of $77.3m, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: M&A activity in pharmaceutical in France
In France pharmaceutical industry, there were 6 M&A deals announced in Q4 2023, worth a total value of $7.4bn, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: M&A activity in pharmaceutical in China
In China pharmaceutical industry, there were 29 M&A deals announced in Q4 2023, worth a total value of $3.5bn, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: M&A activity in pharmaceutical in Canada
In Canada pharmaceutical industry, there were 19 M&A deals announced in Q4 2023, worth a total value of $247m, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: private equity deals in pharmaceutical in the UK
In the UK pharmaceutical industry, there were 6 private equity deals announced in Q4 2023, worth a total value of $30.7m, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: M&A activity in pharmaceutical in the US
In the US pharmaceutical industry, there were 210 M&A deals announced in Q4 2023, worth a total value of $64.6bn, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: M&A activity in pharmaceutical in India
In India pharmaceutical industry, there were 19 M&A deals announced in Q4 2023, worth a total value of $7.4bn, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: private equity deals in pharmaceutical in the US
In the US pharmaceutical industry, there were 31 private equity deals announced in Q4 2023, worth a total value of $700.5m, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: M&A activity in pharmaceutical in Japan
In Japan pharmaceutical industry, there were 19 M&A deals announced in Q4 2023, worth a total value of $1.5bn, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: M&A activity in pharmaceutical in the UK
In the UK pharmaceutical industry, there were 33 M&A deals announced in Q4 2023, worth a total value of $779.7m, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: M&A activity in pharmaceutical in Germany
In Germany pharmaceutical industry, there were 7 M&A deals announced in Q4 2023, worth a total value of $45m, according to GlobalData's Deals Database.
View ArticleChina-US tensions are spilling into the biotech sector
The biotech sector faces another blow as US legislators take aim at Chinese-owned companies over national security concerns.
View ArticlePutting compliance and quality at the heart of pharmaceutical supply chains
With an era of digital transformation promising to optimise pharmaceutical supply chains, how are companies learning to embrace the change?
View Article
